Our focus:

Commercialize CAR-T cell therapeutics that treat metastatic cancer arising from the gastrointestinal tract.

Discover how the GCC biomarker sets our CAR-Ts apart from existing therapies.

GCC: a marker for metastatic colorectal cancer